Skip to main content
Log in

Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibility

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

The court narrowly ruled that business methods may be patent eligible, while striking down the primacy of its main test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Number of amicus briefs from biotech and pharma sector vis-à-vis Bilski v. Kappos.
Figure 2: Amicus briefs from biotech and pharma sector supporting or against Bilski machine-or-transformation test.

References

  1. Langer, E.S. Realistic expectations likely to prevail in 2010. Gen. Eng. News (March 1, 2010).

    Google Scholar 

  2. In re Bilski, 545 F.3d 943 (Fed. Cir. 2008) (en banc).

  3. Simmons, W.J. Nat. Biotechnol. 27, 245–248 (2009).

    Article  CAS  Google Scholar 

  4. In re Bilski, 545 F.3d at 954.

  5. Diamond v. Diehr, 450 US 175, 185 (1981).

  6. Lab Corp. v. Metabolite (Fed. Cir. 2004).

  7. Gottschalk v. Benson, 409 US 63 (1972).

  8. Parker v. Flook, 437 US 584 (1978).

  9. Bilski v. Kappos, 561 US (2010) at 8.

  10. Association for Molecular Pathology et al. v. USPTO et al. 1:09 cv-04515 (SDNY).

  11. Prometheus Laboratories v. Mayo Collaborative Servs., 581 F.3d 1336 (Fed. Cir. 2009).

  12. 561 US (2010) - Kennedy, p. 9.

  13. 561 US (2010) - Kennedy, pp. 12–13.

  14. Diamond v. Chakrabarty 447 US 303 (1980).

  15. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuNovartisCorp.pdf

  16. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuCarisDiagnostics.pdf

  17. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuGaBio.pdf

  18. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuUnivofSFlorida.pdf

  19. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_PetitionerAmCuAChakrabarty.pdf

  20. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCuPrometheusLabs.pdf

  21. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCu2PersonalizedMedOrgs.pdf

  22. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCuMedtronic.pdf

  23. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCuPhRMA.pdf

  24. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_RespondentAmCuKEI.pdf

  25. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_RespondentAmCu2PharmCos.pdf

  26. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_RespondentAmCu5MedicalGrps.pdf

Download references

Acknowledgements

The views expressed are solely the author's and do not represent those of Sughrue Mion and its clients, and are subject to changes in the art and law. The author thanks An Kang Li and Stuart Levy for their cotributions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J Simmons.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simmons, W. Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibility. Nat Biotechnol 28, 801–805 (2010). https://doi.org/10.1038/nbt0810-801

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0810-801

  • Springer Nature America, Inc.

This article is cited by

Navigation